fbpx

molecules of the month

ONO-8430506

potent oral autotaxin phosphodiesterase inh.

orally efficacious in xenograft

from HTS and ligand-based design

ACS Med. Chem. Lett., May 19, 2020

Ono Pharmaceutical, Osaka, JP

Structure of autotaxin inhibitor ONO-8430506
1 min read

ONO-8430506 is a potent autotaxin phosphodiesterase inhibitor with significant oral exposure and low clearance in higher species. Autotaxin contributes to lysophosphatidic acid (LPA) production has been explored as a target in various diseases involving LPA signalling including IPF (GLPG1690, Ph. III), hyperplasia, and cancer (this paper). ONO-8430506 was first disclosed several years ago but the details around its discovery are disclosed here, including the clever strategy to “hybridize” an HTS hit with an endogenous ligand.


request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.


already a member? log in: